Dong-A exports new antibiotic to US

Published: 2007-03-02 06:57:00

Updated: 2007-03-02 06:57:00

Dong-A Pharmaceutical Co., the nation's largest drugmaker, said on February 27 that it had signed a contract with the U.S.-based Trius Therapeutics in San Diego, for the development and marketing of a novel antibiotic (DA-7278) worldwide.

DA-7157, oxazolidinone antibiotic, showed four fold better in vitro antibacterial activity than the conventional compounds against VRE (Vancomycin-Resistan...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.